Our Focus Areas
Disease Areas
Parkinson's
Parkinson's is a degenerative disorder of the brain, specifically affecting the area of the brain called the Substantia Nigra which is located in the Basal Ganglia, a group of brain structure involved in motor control. Some of the common characteristics of Parkinson's include shuffling gait, resting tremor, reduced arm swing and cognitive changes. Parkinson's is the fastest growing neurological condition in the world.
Multiple Systems Atrophy
Multiple Systems Atrophy (MSA) is a neurodegenerative condition that affects people's balance, movement and autonomic nervous system functions. People with MSA display signs of parkinsonism, cerebellar ataxia and autonomic dysfunction. There are two types, MSA-Parkinson's type which resembles idiopathic Parkinson's and MSA-Cerebellar type which combines features of cerebellar ataxia.
Progressive Supranuclear Palsy
Progressive Supranuclear Palsy can cause problems with people's movement, balance, cognition, speech and swallowing. The condition worsens over time (progressive), causes weakness (palsy) due to damage above clusters of nerve cells that control eye movements (supranuclear).
Our Research
The UK PD-CSG will support both Commercial and Non-Commercial Parkinson's clinical trials across the UK. These studies will typically have the overarching theme of working towards the discovery of disease-modifying therapies which would slow down the worsening of Parkinson's. This is the single biggest need for Parkinson's disease research.
We will also support clinical trials which aim to improve the symptoms of Parkinson's.